Cargando…

Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response

Determining the protection an individual has to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants of concern (VoCs) is crucial for future immune surveillance, vaccine development, and understanding of the changing immune response. We devised an informative assay to current ELISA-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doykov, Ivan, Baldwin, Tomas, Spiewak, Justyna, Gilmour, Kimberly C., Gibbons, Joseph M., Pade, Corinna, Reynolds, Catherine J., Áine McKnight, Noursadeghi, Mahdad, Maini, Mala K., Manisty, Charlotte, Treibel, Thomas, Captur, Gabriella, Fontana, Marianna, Boyton, Rosemary J., Altmann, Daniel M., Brooks, Tim, Semper, Amanda, Moon, James C., Kevin Mills, Heywood, Wendy E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372021/ https://www.ncbi.nlm.nih.gov/pubmed/35975199 http://dx.doi.org/10.1016/j.crmeth.2022.100279

Ejemplares similares

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
por: Captur, Gabriella, et al.
Publicado: (2022)

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity
por: Altmann, Daniel M., et al.
Publicado: (2023)

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
por: Manisty, Charlotte, et al.
Publicado: (2021)

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
por: Reynolds, Catherine J., et al.
Publicado: (2021)

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
por: Reynolds, Catherine J., et al.
Publicado: (2022)

Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection
por: Manisty, Charlotte, et al.
Publicado: (2021)

Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections
por: Chandran, Aneesh, et al.
Publicado: (2022)

Asymptomatic health-care worker screening during the COVID-19 pandemic – Authors' reply
por: Treibel, Thomas A, et al.
Publicado: (2020)

HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19
por: Astbury, Stuart, et al.
Publicado: (2022)

Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection
por: Milighetti, Martina, et al.
Publicado: (2023)

Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study
por: Gupta, Rishi K, et al.
Publicado: (2021)

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
por: Reynolds, Catherine J., et al.
Publicado: (2020)

COVID-19: PCR screening of asymptomatic health-care workers at London hospital
por: Treibel, Thomas A, et al.
Publicado: (2020)

Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
por: Swadling, Leo, et al.
Publicado: (2021)

COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
por: Milojkovic, Dragana, et al.
Publicado: (2022)

Longitudinal assessment of symptoms and risk of SARS-CoV-2 infection in healthcare workers across 5 hospitals to understand ethnic differences in infection risk.
por: Valdes, Ana M., et al.
Publicado: (2021)

Curbside particulate matter and susceptibility to SARS–CoV-2 infection
por: Miyashita, Lisa, et al.
Publicado: (2023)

New Perspectives in Dried Blood Spot Biomarkers for Lysosomal Storage Diseases
por: Spiewak, Justyna, et al.
Publicado: (2023)

The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19
por: Usai, Carla, et al.
Publicado: (2022)

Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses
por: Marno, Kelly, et al.
Publicado: (2013)

Niemann–Pick type C disease as proof‐of‐concept for intelligent biomarker panel selection in neurometabolic disorders
por: Papandreou, Apostolos, et al.
Publicado: (2022)

Clinical academic research in the time of Corona: A simulation study in England and a call for action
por: Banerjee, Amitava, et al.
Publicado: (2020)

Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers
por: Joy, George, et al.
Publicado: (2021)

‘The long tail of Covid-19’ - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients
por: Doykov, Ivan, et al.
Publicado: (2021)

Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses
por: Marno, Kelly M, et al.
Publicado: (2014)

Risk of SARS-CoV-2 reinfection after natural infection
por: Boyton, Rosemary J, et al.
Publicado: (2021)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines
por: Altmann, Daniel M, et al.
Publicado: (2022)

The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
por: Boyton, Rosemary J., et al.
Publicado: (2021)

SARS-Cov-2 immune waning and reinfection in care-home settings
por: Altmann, Daniel M, et al.
Publicado: (2021)

Redirected vaccine imprinting by co-administration of COVID-19 and influenza vaccines
por: Boyton, Rosemary J., et al.
Publicado: (2023)

Imprinted hybrid immunity against XBB reinfection
por: Boyton, Rosemary J, et al.
Publicado: (2023)

Immunopathogenesis of Severe Sepsis
por: Noursadeghi, Mahdad, et al.
Publicado: (2000)

Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure
por: Reynolds, Catherine J., et al.
Publicado: (2022)

What policy makers need to know about COVID-19 protective immunity
por: Altmann, Daniel M, et al.
Publicado: (2020)

SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition
por: Altmann, Daniel M., et al.
Publicado: (2021)

Interactions between HIV-1 and the Cell-Autonomous Innate Immune System
por: Towers, Greg J., et al.
Publicado: (2014)

Does tuberculosis threaten our ageing populations?
por: Byng-Maddick, Rachel, et al.
Publicado: (2016)

New Insights into the Limitations of Host Transcriptional Biomarkers of Tuberculosis
por: Noursadeghi, Mahdad, et al.
Publicado: (2021)

Toward a more generalizable blood RNA signature for bacterial and viral infections
por: Gupta, Rishi K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dlrush2qthvjbo5h501t801guj